Herriot Tabuteau

Companies

• Axsome TherapeuticsBoard member Nov 19, 2015 to now¹
• Axsome TherapeuticsChief executive officer Nov 19, 2015 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAxsome Therapeutics AXSM7,351,729 shares²$1.1B at $155.73Aug 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 6, 2026Sold 4,660 shares at $213.95 of Axsome Therapeutics²
• Aug 6, 2026Exercised options 4,660 shares at $4.95 of Axsome Therapeutics²
• Aug 5, 2026Sold 45,004 shares at $212.01 of Axsome Therapeutics²
• Aug 5, 2026Exercised options 45,004 shares at $4.95 of Axsome Therapeutics²
• Jul 1, 2026Sold 49,666 shares at $240.25 of Axsome Therapeutics³
• Jul 1, 2026Exercised options 49,666 shares at $4.95 of Axsome Therapeutics³
• Jun 9, 2026Sold 49,670 shares at $241.01 of Axsome Therapeutics⁴
• Jun 9, 2026Exercised options 49,670 shares at $4.95 of Axsome Therapeutics⁴
• Feb 2, 2026Sold 32,410 shares at $185.60 of Axsome Therapeutics⁵
• Feb 2, 2026Exercised options 32,410 shares at $8.02 of Axsome Therapeutics⁵
• Jan 7, 2026Sold 31,261 shares at $170.38 of Axsome Therapeutics⁶
• Jan 7, 2026Exercised options 31,261 shares at $8.02 of Axsome Therapeutics⁶
• Jan 6, 2026Sold 29,450 shares at $172.33 of Axsome Therapeutics⁶
• Jan 6, 2026Exercised options 29,450 shares at $8.02 of Axsome Therapeutics⁶
• Jan 5, 2026Sold 78,703 shares at $171.28 of Axsome Therapeutics⁶
• Jan 5, 2026Exercised options 78,703 shares at $8.02 of Axsome Therapeutics⁶
• Dec 4, 2025Sold 10,558 shares at $148.18 of Axsome Therapeutics⁷
• Dec 4, 2025Exercised options 10,558 shares at $8.02 of Axsome Therapeutics⁷
• Dec 3, 2025Sold 20,163 shares at $146.94 of Axsome Therapeutics⁷
• Dec 3, 2025Exercised options 20,163 shares at $8.02 of Axsome Therapeutics⁷
• Dec 2, 2025Sold 49,252 shares at $144.59 of Axsome Therapeutics⁷
• Dec 2, 2025Exercised options 49,252 shares at $8.02 of Axsome Therapeutics⁷
• Nov 5, 2025Sold 21,775 shares at $134.49 of Axsome Therapeutics⁸
• Nov 5, 2025Exercised options 21,775 shares at $8.02 of Axsome Therapeutics⁸
• Nov 4, 2025Sold 50,459 shares at $133.79 of Axsome Therapeutics⁸